Molecular detection and genotyping of human papillomavirus in cervical carcinoma biopsies in an area of high incidence of cancer from moroccan women

Journal of Medical Virology

Volumn 81, Issue 4, 2009, Pages 678-684

  Meftah El Khair, M ^a,b   El Mzibri, M ^b   Mhand, R Ait ^a   Benider, A ^c   Benchekroun, N ^c   El Fahime, E M ^d   Benchekroun, M N ^a   Ennaji, M M ^a  

^a HASSAN II UNIVERSITY OF CASABLANCA   (Morocco)

^b CENTRE NATIONAL DE L ENERGIE DES SCIENCES TECHNIQUES NUCLEAIRES   (Morocco)

^c IBN ROCHD UNIVERSITY HOSPITAL   (Morocco)

^d Centre National Pour la Recherche Scientifique et Technique   (Morocco)

Author keywords

Cervical cancer; Genotyping; HPV; Human papillomavirus; Hybridization; PCR

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; CONTROLLED STUDY; FEMALE; GENOTYPE; HISTOPATHOLOGY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; NONHUMAN; PAPILLOMA VIRUS; POLYMERASE CHAIN REACTION; TUMOR BIOPSY; UTERINE CERVIX CARCINOMA; VIRUS DETECTION; BIOPSY; CLASSIFICATION; GENETICS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; ISOLATION AND PURIFICATION; METHODOLOGY; MIDDLE AGED; MOROCCO; NUCLEIC ACID HYBRIDIZATION; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; VIROLOGY; VIRUS INFECTION;

HUMAN PAPILLOMAVIRUS;

VIRUS DNA;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; FEMALE; GENOTYPE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; INCIDENCE; MIDDLE AGED; MOROCCO; NUCLEIC ACID HYBRIDIZATION; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; UTERINE CERVICAL NEOPLASMS;

EID: 62849124766     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21279     Document Type: Article

References (41)

1. Amrani M, Lalaoui K, El Mzibri M, Lazo P, Alaoui Belabbas M. 2003. Molecular detection of human papillomavirus in 594 uterine cervix samples from Moroccan women (147 biopsies and 447 swabs). J Clin Virol 27:286-295.
2. Andersson S, Rylander E, Larson B, Sigurdardottir S, Backlund I, Sallstrom J, Wilander E. 2003. Types of human papillomavirus revealed in cervical adenocarcinomas after DNA sequencing. Oncol Rep 10:175-179.
3. Andersson S, Mints M, Sallstrom J, Wilander E. 2005. The relative distribution ofoncogenic types ofhuman papillomavirus in benign, pre-malignant and malignant cervical biopsies. A study with human papillomavirus deoxyribonucleic acid sequence analysis. Cancer Detect Prev 29:37-41.
4. Ault KA. 2003. Human papillomavirus infections: Diagnosis, treatment, and hope for a vaccine. Obstet Gynecol Clin North Am 30:809-817.
5. Bauer HM, Ting Y, Greer CE, Chambers JC, Tashiro JC, Chimera CL, Reingold A, Manos M. 1991. Genital human papillomavirus infection in female university students as determined by a PCR- based method. JAMA 256:472-477.
6. Bayo S, Bosch FX, de Sanjosé S, Muñoz N, Combita AL, Coursaget P, Diaz M, Dolo A, van den Brule AJ, Meijer CJ. 2002. Risk factors of invasive cervical cancer in Mali. Int J Epidemiol 31:202 -209.
7. Beby-Defaux A, Bourgoin A, Ragot S, Battandier, Lemasson JM, Renaud O, Bouguermouh S, The Practitioners of the Centre d'Examens de Sante de la Caisse Primaire d'Assurance, Maladie de la Vienne, Agius G, 2004. Human papillomavirus infection ofthe cervix uteri in women attending a Health Examination Center of the French social security. J Med Virol 73:262-268.
8. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV. 1995. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 87:796-802.
9. Brestovac B, Harnett GB, Smith DW, Shellam GR, Frost FA. 2005. Human papillomavirus genotypes and their association with cervical neoplasia in a cohort of Western Australian women. J Med Virol 76:106-110.
10. Castellsagué X, Menéndez C, Loscertales MP, Kornegay JR, dos Santos F, Gómez-Olivé FX, Lloveras B, Abarca N, Vaz N, Barreto A, Bosch FX, Alonso P. 2001. Human papillomavirus genotypes in rural Mozambique. Lancet 358:1429-1430.
11. Chabaud M, Le Cann P, Mayelo V, Leboulleux D, Diallo AS, Enogat N, Afoutou JM, Anthonioz P, Coll-Seck AM, Coursaget P. 1996. Detection by PCR of human papillomavirus genotypes in cervical lesions of Senegalese women. J Med Virol 49:259-263.
12. Chaouki N, Bosch FX, Munoz N, Meijer CJLM, El Gueddari B, El Ghazi A, et al. 1998. The viral origin of cervical cancer in Rabat, Morocco. Int J Cancer 75:546-554.
13. Chen S, Fairley CK, Tabrizi SN, Quinn MA, Garland SM. 1993. Southern blot and dot blot hybridisation compared to PCR for the detection of human papillomavirus DNA in biopsies of the uterine cervix from women with dysplasia. Clin Diagn Virol 1:187-194.
14. Deluca GD, Lucero RH, Martin de Civetta MT, Vicente L, de Gorodner OL, Schelover E, Alonso JM. 2004. Human papillomavirus genotypes in women with cervical cytological abnormalities from an area with high incidence of cervical cancer. Rev Inst Med Trop Sao Paulo 46:9-12.
15. Denny LA, Wright TC Jr. 2005. Human papillomavirus testing and screening. Best Pract Res Clin Obstet Gynaecol 19:501 -515.
16. Eiben GL, Velders M, Kast M. 2002. The cell mediated immune response to Human papillomavirus induced cervical cancer: Implications for immunotherapy. Adv cancer Res 86:113-148.
17. Fife KH, Cramer HM, Schroeder JM, Brown DR. 2001. Detection of multiple human papillomavirus types in the lower genital tract correlates with cervical dysplasia. J Med Virol 64:550-559.
18. Frappart L, Fontaniére B, Lucas E, Sankaranarayanan R. 2004. Histopathology of the uterine cervix. In Histopathology and cytopathology of the Uterine Cervix - Digital Atlas.
19. Ghaffari SR, Sabokbar T, Mollahajian H, Dastan J, Ramezanzadeh F, Ensani F, Yarandi F, Mousavi-Jarrahi A, Mohagheghi MA, Moradi A. 2006. Prevalence of human papillomavirus genotypes in women with normal and abnormal cervical cytology in Iran. Asian Pac J Cancer Prev 7:529-532.
20. Hanahan D, Weinberg RA. 2000. The hallmarks of cancer. Cell 100:57- 70.
21. Herrero R, Castle PE, Schiffman M, Bratti MC, Hildesheim A, Morales J, Alfaro M, Sherman ME, Wacholder S, Chen S, Rodriguez AC, Burk RD. 2005. Epidemiologic profile of type specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis 191:1796-1807.
22. Hopman AH, Smedts F, Dignef W, Ummelen M, Sonke G, Mravunac M, Vooijs GP, Speel EJ, Ramaekers FC. 2004. Transition ofhigh-grade cervical intraepithelial neoplasia to micro-invasive carcinoma is characterized by integration of HPV 16/18 and numerical chromosome abnormalities. J Pathol 202:23-33.
23. Kay P, Soeters R, Nevin J, Denny L, Dehaeck CMC, Williamson AL. 2003. High prevalence of HPV 16 in South African women with cancer of the cervix and cervical intraepithelial neoplasia. J Med Virol 71:265-273.
24. La Ruche G, You B, Mensah-Ado I, Bergeron C, Montcho C, Ramon R, Toure-Coulibaly K, Welffens-Ekra C, Dabis F, Orth G. 1998. Human papillomavirus and human immunodeficiency virus infections: Relation with cervical dysplasia-neoplasia in African women. Int J Cancer 76:480-486.
25. Lalaoui K, El Mzibri M, Amrani M, Belabbas MA, Lazo PA. 2003. Human papillomavirus DNA in cervical lesions from Morocco and its implications for cancer control. Clin Microbiol Infect 9:144-148.
26. Lungu O, Wright TC Jr, Silverstein S. 1992. Typing of human papillomaviruses by polymerase chain reaction amplification with L1 consensus primers and RFLP analysis. Mol Cell Probes 6:145-152.
27. Maleknejad P, Rakhshan M, Kazemi B, Farokh F, Shahsavan S. 2006. Detection of Human Papilomavirus types 16 And 18 in pathologic samples from patients with cervical cancer by PCR and RFLP methods. DARU 14:78-81.
28. Manavi M, Bauer M, Pischinger K, Czerwenka K. 2001. Detection of human papillomavirus on Papanicolaou- stained cervical smears using indirect in situ polymerase chain reaction hybridization. Arch Pathol Lab Med 125:353-357.
29. Morrison EA, Ho GY, Vermund SH, Goldberg GL, Kadish AS, Kelley KF, Burk RD. 1991. Human papillomavirus infection and other risk factors for cervical neoplasia: A case-control study. Int J Cancer 49:6-13.
30. Munoz N, Bosch X, De Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJF, Meijer CJLM, for the International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518-527.
31. Ratnam S, Franco EL, Ferenczy A. 2000. Human papillomavirus testing for primary screening of cervical cancer precursors. Cancer Epidem Biomarkers Prev 9:945-951.
32. Schiffman M, Castle PE. 2003. Human papillomavirus: Epidemiology and public health. Arch Pathol Lab Med 127:930-934.
33. Scott DR, Hagmar B, Maddox P, Hjerpe A, Dillner J, Cuzick J, Sherman ME, Stoler MH, Kurman RJ, Kiviat NB, Manos MM, Schiffman M. 2002. Use of human papillomavirus DNA testing to compare equivocal cervical cytologic interpretations in the United States, Scandinavia, and the United Kingdom. Cancer 96:14-20.
34. Stevens MP, Tabrizi SN, Quinn MA, Garland SM. 2006. Human papillomavirus genotype prevalence in cervical biopsies from women diagnosed with cervical intraepithelial neoplasia or cervi- calcancer in Melbourne, Australia. Int J Gynecol Cancer 16:1017-1024.
35. Ter Melulen J, Eberhardt HC, Luande J, Mgaya HN, Chang-Claude J, Mtiro H, Mhina M, Kashaija P, Ockert S, Yu X, et al. 1992. Human papillomavirus (HPV) infection, HIV infection and cervical cancer in Tanzania, east Africa. Int J Cancer 51:515-521.
36. Ting Y, Manos MM. 1990. Detection and typing of genital human papillomaviruses. In: Innis MA, Gelfand DH, SninskyJJ, White TJ, editors. PCR protocols: A guide to methods and applications. San diego: Academic press. pp 356-367.
37. Tjalma WAA, Van Waes TR, Van den Eeden LEM, Bogers JJPM. 2005. Role of human papillomavirus in the carcinogenesis of squamous cell carcinoma and adenocarcinoma of the cervix. Best Pract Res Clin Obstet Gynaecol 19:469-483.
38. Trottier H, Mahmud S, Costa MC, Sobrinho JP, Franco ED, Rohan TE, Ferenczy A, Villa LL, Franco EL. 2006. Human papillomavirus infections with multiple types and risk ofcervical neoplasia. Cancer Epidemiol Biomarkers Prev 15:1274-1279.
39. Van Der Graaf Y, Molijn A, Doornewaard H, Quint W, van Doorn LJ, Van Den Tweel J. 2002. Human papillomavirus and the long-term risk of cervical neoplasia. Am J Epidemiol 156:158-164.
40. Wei Y, Chou YS,Chu TY. 2007. Detection and typing of minimal human papillomavirus DNA in plasma. Int J Gynaecol Obstet 96:112-116.
41. Wright TC Jr. 2006. Pathology of HPV infection at the cytologic and histologic levels: Basis for a 2-tiered morphologic classification system (Chapter 3). Int J Gynaecol Obstet 94:S22-S31.